Vyvanse™: Consistent symptom control for ADHD

Along with Vyvanse, SHINE is here to provide you with consistent support. SHINE provides free practical tools, tips, and offers to help you create a comprehensive treatment program for your child. With consistent ADHD symptom control and the support of SHINE, there is no stopping your child, even through the challenging homework hours from 4 pm to 6 pm.

Some of the features of SHINE:

	Tips to improve focus, organization and behavior in your child
	Suggestions for working with your child's teachers
	Vyvanse Success Tracker
	Ideas for building and coaching your child's support team
	Additional ADHD information from Shire

Already registered for SHINE? Sign In Here

*Required Fields
*First Name:
*Last Name:
*Address 1:
Address 2:
*City:
*State:
*ZIP Code:
Phone:
*Email (This will be your User Name):
*Email (confirm your User Name):
*Password:
*Password (confirm your password):
*Date of birth of the person with ADHD:
*Gender of the person with ADHD:

All personal information you provide will be kept completely private and will not be used or distributed to anyone for any purpose other than what is explained here.

*1. Has your child been diagnosed with ADHD by a healthcare professional?

Yes

Adderall XR^® is a registered trademark of Shire LLC.

Daytrana^™ is a trademark of Shire Pharmaceuticals Ireland Limited.

Vyvanse^™ is a trademark of Shire LLC.

All other product names are the trademarks of their respective companies.

Important Safety Information

Tell the doctor about any heart conditions, including structural abnormalities, that you, your child, or a family member, may have. Inform the doctor immediately if your child develops symptoms that suggest heart problems, such as chest pain or fainting.

Vyvanse or Adderall XR should not be taken by patients who have advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; glaucoma; a history of problems with alcohol or drugs; agitated states; taken a monoamine oxidase inhibitor (MAOI) within the last 14 days.

Tell your doctor before taking Vyvanse or Adderall XR if you or your child are being treated for or have symptoms of depression (sadness, worthlessness, or hopelessness) or bipolar disorder; have abnormal thought or visions, hear abnormal sounds, or have been diagnosed with psychosis; have had seizures or abnormal EEGs; have or have had high blood pressure; exhibit aggressive behavior or hostility. Tell your doctor immediately if any of these conditions or symptoms develop while taking Vyvanse or Adderall XR.

Abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have also been reported rarely with amphetamine use.

Vyvanse and Adderall XR were generally well tolerated in clinical studies. The most common side effects reported in studies of Vyvanse included: children - decreased appetite, difficulty falling asleep, stomachache, and irritability. The most common side effects reported in studies of Adderall XR included: children - decreased appetite, difficulty falling asleep, stomachache, and emotional lability; adolescents - loss of appetite, difficulty falling asleep, stomachache, and weight loss; adults - dry mouth, loss of appetite, difficulty falling asleep, headache, and weight loss.

Aggression, new abnormal thoughts/behaviors, mania, growth suppression, worsening of motion or verbal tics, and Tourette's syndrome have been associated with use of drugs of this type. Tell your doctor if you or your child have blurred vision while taking Vyvanse or Adderall XR.

Please see our online privacy policy for more information. While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.

LDX1780 03/08